Biotech

Page 3 of 19

The finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team’
Newsletters

The finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team’

By
May 9, 2024
A scientist in a lab coat peers into a microscope in a lab.
Newsletters

AI for drug discovery draws a $1 billion launch—and a lot of hope

By
April 25, 2024
U.S. lawmakers are trying to bar Chinese biotech companies over fears about America’s failure to compete with China in the industry
Politics

U.S. lawmakers are trying to bar Chinese biotech companies over fears about America’s failure to compete with China in the industry

By Didi Tang and The Associated Press
February 19, 2024
Exclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trials
Newsletters

Exclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trials

By
February 6, 2024
AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
Conferences

AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’

By
December 14, 2023
Evofem, the startup trying to survive the broken birth-control market, finally sells itself
Features

Evofem, the startup trying to survive the broken birth-control market, finally sells itself

By
December 13, 2023
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
Health

Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’

By Angel Adegbesan and Bloomberg
October 13, 2023
Republican presidential candidate Vivek Ramaswamy standing behind a podium holding up peace signs.
Politics

How Vivek Ramaswamy, the surprise GOP debate star, made his fortune and triggered his critics

By
August 24, 2023
Noubar Afeyan, co-founder and chairman of Moderna and founder and chief executive officer of Flagship Pioneering.
Features

The Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It’s a tough act to follow

By
August 10, 2023
Portraits of Francis deSouza, Lina Khan, and Carl Icahn.
Leadership

Inside Illumina’s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2 prominent Black Silicon Valley executives

By
July 27, 2023
NYSE trader
Finance

The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%

By Angel Adegbesan and Bloomberg
July 12, 2023
Illumina CEO Francis deSouza resigns after proxy battle with Carl Icahn
Finance

Illumina CEO Francis deSouza resigns after proxy battle with Carl Icahn

By Tiago Ramos Alfaro and Bloomberg
June 11, 2023
Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
Newsletters

Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so

By
May 24, 2023
Pipette adding sample to petri dish with DNA profiles in background
Newsletters

A.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A

By
May 23, 2023
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
Health

How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own

By Arthur Allen and KFF Health News
April 13, 2023

Most Popular